A patient is taking prednisolone 20mg for 15 days. Now how to taper it down to finally stop the drug
Reading File
Finding Sources
Searching PubMed
corticosteroid tapering prednisolone short course withdrawal
Searching the Web
prednisolone 20mg tapering schedule short course 15 days how to stop
Finding Sources
Reading File
Reading File
Here is a clear, evidence-based tapering plan:
Tapering Prednisolone 20mg After 15 Days
Why Taper?
At 15 days, the patient is right at the borderline where HPA axis suppression becomes a concern. According to Fitzpatrick's Dermatology and Goodman & Gilman's Pharmacological Basis of Therapeutics, patients on daily glucocorticoid therapy for longer than 3-4 weeks must be assumed to have adrenal suppression. At exactly 15 days, significant suppression is unlikely - but a brief taper is still the safest and standard approach to avoid a glucocorticoid withdrawal syndrome and give the adrenals a chance to resume function.
Recommended Tapering Schedule
Since the course is short (15 days at 20mg), a rapid taper over ~1-2 weeks is appropriate:
| Days | Dose |
|---|---|
| Days 1-3 | 15 mg/day |
| Days 4-6 | 10 mg/day |
| Days 7-9 | 5 mg/day |
| Days 10-12 | 2.5 mg/day (or alternate day 5mg) |
| Day 13 onwards | Stop |
This completes the taper in about 12-13 days. Alternatively, a simpler approach:
- Reduce by 5 mg every 3-5 days: 20 → 15 → 10 → 5 → stop.
Key Points
-
Short courses (<3 weeks) generally do not cause clinically significant adrenal suppression. The general principle from Goodman & Gilman is that overly rapid withdrawal after prolonged HPA suppression causes adrenal insufficiency - at 15 days, full recovery is expected within days to a few weeks.
-
Watch for the glucocorticoid withdrawal syndrome: Even without true adrenal insufficiency, some patients experience fever, myalgia, arthralgias, and malaise during rapid tapering. Slow the taper if these occur.
-
The underlying disease matters: If symptoms of the original condition (e.g., asthma, allergy, autoimmune flare) return during the taper, the taper may need to be slowed or the dose held temporarily.
-
Stress coverage: Advise the patient that during this taper period, if they develop significant illness, trauma, or need surgery, they should inform their doctor - additional steroid coverage may be needed.
-
No HPA axis testing is necessary at this short duration unless the patient develops symptoms suggestive of adrenal insufficiency (fatigue, hypotension, hyponatremia, hypoglycemia).
When to slow or extend the taper
- Patient reports significant myalgia, fatigue, or joint pain (withdrawal syndrome)
- The underlying disease flares up
- If the dose was actually higher or the duration longer than 15 days
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics; Fitzpatrick's Dermatology, p. 3415
This is a shared conversation. Sign in to Orris to start your own chat.